You have no items in your shopping cart.
Description
Research Area
Images & Validation
−| Tested Applications | IF, WB |
|---|---|
| Dilution Range | Western Blot 1:500, Immunofluorescence 1:100 – 1:300 |
| Reactivity | Human |
| Application Notes |
Key Properties
−| Antibody Type | Primary Antibody |
|---|---|
| Host | Mouse |
| Clonality | Monoclonal |
| Isotype | Mouse IgG1 |
| Clone No. | BOD4 |
| Target | IL-2 |
| Conjugation | Unconjugated |
Storage & Handling
−| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
|---|---|
| Buffer/Preservatives | Phosphate-buffered solutions, pH 7.2, 50% Glycerol, 0.025% ProClin 300 was added as a preservative |
| Expiration Date | 12 months from date of receipt. |
| Disclaimer | For research use only |
Similar Products
−Anti-IL-2R alpha (CD25) [Basiliximab] [orb1152522]
Blocking, FC, IF, IHC, WB
Human, Primate
Human
Monoclonal
Unconjugated
0.2 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Recombinant Human Interleukin-2 (hIL-2) proteins. Nitrocellulose membrane was then blocked for an hour before being incubated with orb1735091 overnight at 4°C. Anti IL-2 antibody [MB2] at 1/500 dilution.
Quick Database Links
Documents Download
Request a Document
Protocol Information
IL-2 Mouse Monoclonal Antibody (orb1735091)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review






![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_1.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_2.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_3.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_4.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_5.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_6.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152523_1.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152523_2.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152523_3.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152523_4.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152523_5.png)









